Evidence map›Paper›PMID 20507746›Full record

ArticleEmerging infectious diseases2010

Increase in pilus islet 2-encoded pili among Streptococcus pneumoniae isolates, Atlanta, Georgia, USA.

Dorothea Zähner, Aditya Gudlavalleti, David S Stephens

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecular Epidemiology ofInternational journal of molecular sciences · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Pilus ofFrontiers in cellular and infection microbiology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The prevalence of pilus islets inAccess microbiology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Panel 5: Microbiology and immunology panel.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dorothea ZähnerDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, USA. dzahner@emory.edu
Aditya Gudlavalleti
David S Stephens

Funding

Molecular bssis of mef-mediated antibiotic resistance in Streptococcus pneumoniaeR01AI070829 · NIAID · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2010
$1.5M
NIAID NIH HHS R01 AI070829NIAID NIH HHS R01AI 070829
6 · The paper itself

Abstract

To define the prevalence of pilus islet 2 (PI-2)-encoded pili in Streptococcus pneumoniae in a geographically defined area, we examined 590 S. pneumoniae isolates from population-based surveillance of invasive pneumococcal disease in Atlanta, Georgia, USA, 1994-2006. In 2006, PI-2 was present in 21% of all invasive isolates, including serotypes 1 (100%), 7F (89%), 11A (21%), 19A (40%), and 19F (75%). Only serotype 19F is included in the 7-valent pneumococcal conjugate vaccine that is in use worldwide. In 1999, PI-2-containing isolates were of the same serotypes but accounted for only 3.6% of all invasive isolates. The increase of PI-2 in 2006 resulted predominantly from the emergence of serotype 19A isolates of sequence type 320 and the expansion of serotype 7F isolates. The increase in PI-2-containing isolates and the finding that isolates of all identified serotypes expressed highly conserved PI-2 pili supports their potential as a vaccine candidate.

Indexed as

Genes, BacterialDNA, BacterialDrug Resistance, Multiple, BacterialFimbriae, BacterialGenetic VariationGeorgiaHumansMicrobial Sensitivity TestsPneumococcal InfectionsSequence Analysis, DNAStreptococcus pneumoniaeDNA, Bacterial

Identifiers

PMID20507746
PMCPMC3086225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.